Welcome to LookChem.com Sign In|Join Free

CAS

  • or

959122-10-2

Post Buying Request

959122-10-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Cyclopentanecarboxylic acid, 2-[[4'-[[(phenylaMino)carbonyl]aMino][1,1'-biphenyl]-4-yl]carbonyl]-, Methyl ester, (1R,2R)-

    Cas No: 959122-10-2

  • No Data

  • No Data

  • No Data

  • GZ HONESTCHEM CO., LTD
  • Contact Supplier

959122-10-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 959122-10-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,1,2 and 2 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 959122-10:
(8*9)+(7*5)+(6*9)+(5*1)+(4*2)+(3*2)+(2*1)+(1*0)=182
182 % 10 = 2
So 959122-10-2 is a valid CAS Registry Number.
InChI:InChI=1/C27H26N2O4/c1-33-26(31)24-9-5-8-23(24)25(30)20-12-10-18(11-13-20)19-14-16-22(17-15-19)29-27(32)28-21-6-3-2-4-7-21/h2-4,6-7,10-17,23-24H,5,8-9H2,1H3,(H2,28,29,32)/t23-,24-/m1/s1

959122-10-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl (1R,2R)-2-({4'-[(phenylcarbamoyl)amino]-4-biphenylyl}carbo nyl)cyclopentanecarboxylate

1.2 Other means of identification

Product number -
Other names methyl (1R,2R)-2-({4'-[(anilinocarbonyl)amino]-1,1'-biphenyl-4-yl}carbonyl)cyclopentanecarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:959122-10-2 SDS

959122-10-2Downstream Products

959122-10-2Relevant articles and documents

Process development of a diacyl glycerolacyltransferase-1 inhibitor

Ravn, Matthew M.,Wagaw, Seble H.,Engstrom, Kenneth M.,Mei, Jianzhang,Kotecki, Brian,Souers, Andrew J.,Kym, Philip R.,Judd, Andrew S.,Zhao, Gang

, p. 417 - 424 (2011/04/22)

A synthesis of a selective diacyl glycerolacyltransferase-1 (DGAT-1) inhibitor, 1, is described. The synthesis illustrates a diketone Favorskii reaction on 9 in place of the more common ketoester variant for generation of the dicarboxycyclopentane core, t

Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor

Zhao, Gang,Souers, Andrew J.,Voorbach, Martin,Falls, H. Doug,Droz, Brian,Brodjian, Sevan,Yau, Yi Lau,Iyengar, Rajesh R.,Gao, Ju,Judd, Andrew S.,Wagaw, Seble H.,Ravn, Matthew M.,Engstrom, Kenneth M.,Lynch, John K.,Mulhern, Mathew M.,Freeman, Jennifer,Dayton, Brian D.,Wang, Xiaojun,Grihalde, Nelson,Fry, Dennis,Beno, David W. A.,Marsh, Kennan C.,Su,Diaz, Gilbert J.,Collins, Christine A.,Sham, Hing,Reilly, Regina M.,Brune, Michael E.,Kym, Philip R.

, p. 380 - 383 (2008/09/17)

A highly potent and selective DGAT-1 inhibitor was identified and used in rodent models of obesity and postprandial chylomicron excursion to validate DGAT-1 inhibition as a novel approach for the treatment of metabolic diseases. Specifically, compound 4a conferred weight loss and a reduction in liver triglycerides when dosed chronically in DIO mice and depleted serum triglycerides following a lipid challenge in a dose-dependent manner, thus, reproducing major phenotypical characteristics of DGAT-1-/- mice.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 959122-10-2